Which SWOT Weaknesses Could Kill the Decision?

Most SWOT weaknesses are awkward but survivable. One of them can stop the entire move. The test is not severity scoring. It is whether the weakness rests on a condition that, if it shifts, breaks the logic the approval depends on. That is the weakness worth finding before Friday.

I have sat through SWOT workshops where the wall was covered in sticky notes by lunch and the board wanted approval by Friday. Then one weakness gets circled, the sponsor still wants to proceed, and the room finally brushes against the real question: which SWOT weaknesses could kill the decision?

Most weaknesses are awkward but survivable. A smaller group can break the economics or leave you with no room to recover once money is committed. That is the line that matters. If the decision only works while a weakness stays harmless, the weakness belongs in the approval itself, not in a note saying the team will monitor it later.

SWOT weaknesses that could kill the decision are internal flaws severe enough to stop or redesign a proposed course of action before approval.

Which SWOT weaknesses could kill the decision, and which do not

A SWOT grid gives every weakness the same visual status. That is one reason the exercise flatters people who want momentum more than judgement. In Hill and Westbrook's study of 50 UK manufacturing companies, 20 teams produced outputs averaging more than 40 items, and none used the outputs in later strategy formulation. I am not surprised. Once a nuisance weakness and a fatal one are parked in the same box, the sponsor can still ask for Friday approval and the consultant who sold the workshop can still call the day rigorous. Even a clean SWOT analysis only gets you to a list.

I see the same dodge in board papers. A fatal weakness is described in the appendix and stripped of force before the approval page. That suits the machinery nicely. The recommendation survives, and the people who like notes more than decisions get to say the weakness was recorded. Recorded by whom is not the point. Recording it does not make the decision safer.

In my experience, the real failure comes a step later. Teams treat 'our brand is weak' and 'we cannot survive one bad quarter' as if they are the same kind of problem, because the grid has flattened both into a bullet point. They are not. The first may slow you down. The second can reverse the decision after commitment. That is why I move straight from the grid into the Universal Decision-Making Method: rewrite the weakness as an assumption, then test how much of the decision rests on it.

Which SWOT weaknesses could kill the decision by removing room to recover

Carillion is a clean case. The company kept taking work while the balance sheet was already too weak for the commitments it was carrying. The House of Commons Library summary and the related Parliament briefing record a GBP845 million contract provision in July 2017, then a further GBP1.2 billion hit disclosed in September. By the January 2018 liquidation, Carillion had nearly GBP7 billion of liabilities and about GBP29 million of cash. I do not care whether that weakness was labelled a risk or a watch item in the board paper. It should have stopped further contract-taking and forced retrenchment before liquidation made the choice for them.

WeWork carried a different mechanism and the same result. The 2019 S-1 filing set out run-rate revenue of USD3.3 billion as of June 30, 2019, committed revenue backlog of USD4.0 billion, and net losses of USD1.9 billion for 2018. Business Insider put future lease obligations at about USD47 billion. In Deciding, Roger Estall and I say the useful question is whether the remaining doubt could reverse the call. To answer which SWOT weaknesses could kill the decision, I ask whether the move still works when the weakness turns real. In WeWork's case, uninterrupted growth and fresh capital were doing too much of the work, so even a modest slowdown could turn expansion into a financing problem.

Take the weakness your team circled and rewrite it as a live failure, then ask whether the decision survives it. Start the Walk →

A weakness becomes fatal when you will detect it too late

I ask two questions. If this weakness is real, does the decision still achieve its purpose? If conditions worsen, do we still have time to respond? That is the test the SWOT box never applies, because the box exists to collect observations, not to stop a bad approval. The risk function often prefers a note to a veto; a note keeps the paper moving and nobody has to own the delay.

Quibi makes the timing problem obvious. The company raised about USD1.75 billion. It launched as a mobile-only premium streaming service and shut down after roughly six months. Its own shutdown letter confirms the closure. Business Insider reported that Quibi had projected more than 7 million subscribers after year one and had roughly 500,000 around the shutdown. I have watched this kind of forecasting fantasy before. The model demanded that customers behave exactly as the spreadsheet required, which is a pleasant arrangement if the spreadsheet is in charge of the market. Once that weakness was built into the launch, recovery room had already gone.

Some weaknesses are survivable because the signal arrives early and the commitment can still be trimmed. Others are fatal because the signal arrives after the contracts are signed or the launch is public. I learned long ago that timing matters as much as severity. A weakness that bites late will not be rescued by a prettier register. It needs a smaller commitment now, or a different decision altogether.

A weakness matters when the decision rests on it and you will discover the failure too late to repair it. That is why I care so much about whether the weakness is load-bearing. If the launch only pays for itself when twenty enterprise prospects convert inside ninety days, the weakness is already sitting inside the economics. A good team will say that plainly. A weak one will bury it in an appendix and call that prudence.

What to do when a weakness is serious but not fatal

A serious weakness does not always kill the decision, but it must change the design before approval. The useful part of the VA's Health Care Failure Mode and Effect Analysis is that it forces the room to ask how bad the failure would be and whether you would see it in time; then it checks whether the claimed control does anything at all. The underlying HFMEA paper scores hazard from 1 to 16, which matters less to me than the discipline behind it. I have found that once you ask for a real control, not a comforting sentence, the conversation gets shorter very quickly.

Take 'weak sales capability'. That phrase is harmless because it does not require a decision. Rewrite it as a live failure: if the first twenty enterprise prospects do not convert within ninety days, the rollout will not cover its fixed cost. Now you can shrink the rollout or delay approval while you test the assumption. That is the work of turning a SWOT into a decision. Name the trigger and the owner, then state now what result stops the rollout. If the weakness stays high influence and low confidence after redesign, stop.

This is also why so much SWOT strategic planning produces paperwork rather than judgement, and why plain SWOT analysis so often leaves a fatal weakness untouched. The weakness stays in the appendix because nobody in the room wants to kill the pet project, which protects the meeting and leaves the decision exposed.

When people ask me which SWOT weaknesses could kill the decision, I tell them to rewrite the weakness as a live failure and ask whether the move survives it. If it does not, a note in the appendix is simply permission to fail expensively.

---

Grant Purdy is the co-author, with Roger Estall, of Deciding (2020), and the architect of the Universal Decision-Making Method.